Butterfly Network, Inc. to Report Third Quarter 2023 Financial Results on November 2, 2023
18 Ottobre 2023 - 10:14PM
Business Wire
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital
health company transforming care with handheld, whole-body
ultrasound, announced that it will report third quarter 2023
financial results and provide a business update on November 2,
2023, after the market closes.
Joseph DeVivo, President, Chief Executive Officer and Chairman
of the Board, and Heather Getz, Executive Vice-President, and Chief
Financial and Operations Officer, will host a conference call and
webcast at 4:30 pm ET on November 2, 2023, to discuss third quarter
2023 financial results and operational progress.
The conference call will be broadcast live in listen-only mode
via a webcast on Butterfly’s Investor Relations website at
Events & Presentations.
Individuals interested in listening to the conference call on
your telephone may do so by dialing approximately ten minutes prior
to start time:
US domestic callers: +1 (833) 470-1428 Global
Dial-In Numbers:
https://www.netroadshow.com/events/global-numbers?confId=52698
Access Code: 606901
After the live webcast, the call will be archived on Butterfly’s
Investor Relations page. In addition, a telephone replay of the
call will be available until November 16, 2023, by dialing:
US domestic callers: 1 (866) 813-9403 Canada: 1
(226) 828-7578 All other callers: +44 (204) 525-0658 Access Code:
465750
About Butterfly Network, Inc.
Founded by Dr. Jonathan Rothberg in 2011, and recently listed on
the New York Stock Exchange through a business combination with
Longview Acquisition Corp., Butterfly created the world's first
handheld, single probe whole-body ultrasound system using
semiconductor technology, the Butterfly iQ+. Butterfly's mission is
to democratize medical imaging and contribute to the aspiration of
global health equity, making high-quality ultrasound affordable,
easy-to-use, globally accessible, and intelligently connected,
including for the 4.7 billion people around the world lacking
access to ultrasound. Through its proprietary Ultrasound-on-Chip™
technology, Butterfly is paving the way for earlier detection and
remote management of health conditions around the world. The
Butterfly iQ+ can be purchased online today by healthcare
practitioners in the United States, Australia, Austria, Belgium,
Canada, Denmark, Finland, France, Germany, Ireland, Italy, the
Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden,
Switzerland, and the United Kingdom. Butterfly iQ+ is a
prescription device intended for qualified healthcare professionals
only. For more information, visit
www.butterflynetwork.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231018932412/en/
Investors Heather Getz
hgetz@butterflynetinc.com
Media Liz Learned llearned@butterflynetinc.com
Grafico Azioni Butterfly Network (NYSE:BFLY)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Butterfly Network (NYSE:BFLY)
Storico
Da Mag 2023 a Mag 2024